Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarct
Authors:
Open Access
- 11 September 2008
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 16 (1) , 127-135
Abstract
The development of clinically beneficial myocardial gene therapy has been slowed by reliance on the use of viral carriers and non-physiologic, constitutive gene expression. To specifically address these issues, we have developed a non-viral gene carrier, water-soluble lipopolymer (WSLP), and an ischemia-inducible plasmid construct expressing vascular endothelial growth factor (VEGF), pRTP801-VEGF, to treat myocardial ischemia and infarction. Rabbits underwent ligation of the circumflex artery followed by injection of (a) an ischemia-inducible VEGF gene construct in a WSLP carrier; (b) a constitutively expressed, or unregulated, SV-VEGF gene construct in a WSLP carrier; (c) WSLP carrier alone; or (d) no injection therapy. Following 4 weeks treatment, ligation alone resulted in infarction of 48±7% of the left ventricle. With injection of WSLP carrier alone, 49±6% of the left ventricle was infarcted (P=NS). The constitutively expressed gene construct, SV-VEGF, reduced the infarct size to 32±7% of the left ventricle (P=0.007). The ischemia-inducible gene construct, RTP801-VEGF, further reduced the infarct size to 13±4% of the left ventricle (P<0.001). The use of a non-viral carrier to deliver an ischemia-inducible VEGF construct is effective in the treatment of acutely ischemic myocardium.Keywords
This publication has 46 references indexed in Scilit:
- Non-viral delivery of interleukin-2 and soluble Flk-1 inhibits metastatic and primary tumor growth in renal cell carcinomaGene Therapy, 2007
- Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3′-untranslated region for the VEGF gene therapyJournal of Controlled Release, 2006
- Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheepGene Therapy, 2006
- Intravenous administration of vascular endothelial growth factor improves cardiac performance and inhibits cardiomyocyte apoptosisGrowth Factors, 2006
- Cardiomyocyte hyperplasia after plasmid‐mediated vascular endothelial growth factor gene transfer in pigs with chronic myocardial ischemiaThe Journal of Gene Medicine, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Arteriogenesis Induced by Intramyocardial Vascular Endothelial Growth Factor 165 Gene Transfer in Chronically Ischemic PigsHuman Gene Therapy, 2003
- Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121The Annals of Thoracic Surgery, 2000
- Nonviral Gene Transfer for Studying Signaling in Comparative Developmental BiologyaAnnals of the New York Academy of Sciences, 1998
- A novel cationic liposome reagent for efficient transfection of mammalian cellsBiochemical and Biophysical Research Communications, 1991